Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents
Clinical trial NCT00262041 · COMPLETED
Trial details
- NCT number
- NCT00262041
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2006-03-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.